Patent for a kit determining the malignancy staging of prostate cancer
Scientific Achievement for 2021 of the Institute for Biology and Immunology of Reproduction. A method and a kit for the diagnosis of new mutant forms of fusion between two genes, (TMPRSS2 and ERG) with relevance for the determination of the degree of malignancy of prostate cancer is the most significant scientific and applied achievement for 2021 of the Institute of Biology and Immunology of Reproduction (IBIR). […]
